Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New chief medical officer at Tengion

This article was originally published in Scrip

Executive Summary

Tengion, a US clinical-stage biotechnology company, has appointed Dr Sunita Sheth chief medical officer and vice-president of clinical and regulatory affairs. She will be responsible for developing clinical development strategies and implementing clinical trials. Dr Sheth most recently served as vice-president of the speciality care business unit for Pfizer as part of its acquisition of Wyeth. Before that, she spent four years at Wyeth, most recently as vice-president of cardiovascular, metabolic and infectious diseases.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts